Broadcasting
Compare Stocks
5 / 10Stock Comparison
CURI vs AMCX vs WBD vs FUBO vs DIS
Revenue, margins, valuation, and 5-year total return — side by side.
Entertainment
Entertainment
Broadcasting
Entertainment
CURI vs AMCX vs WBD vs FUBO vs DIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Broadcasting | Entertainment | Entertainment | Broadcasting | Entertainment |
| Market Cap | $181M | $376M | $67.97B | $302M | $187.52B |
| Revenue (TTM) | $72M | $2.30B | $37.22B | $2.72B | $97.26B |
| Net Income (TTM) | $-6M | $52M | $-2.15B | $156M | $11.22B |
| Gross Margin | 56.6% | 37.3% | 38.2% | 11.1% | 37.2% |
| Operating Margin | -10.2% | 9.2% | 4.5% | -2.6% | 15.5% |
| Forward P/E | 88.0x | 5.2x | 93.5x | — | 16.0x |
| Total Debt | $12M | $1.85B | $32.57B | $670M | $44.88B |
| Cash & Equiv. | $18M | $502M | $4.57B | $452M | $5.70B |
CURI vs AMCX vs WBD vs FUBO vs DIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CuriosityStream Inc. (CURI) | 100 | 31.5 | -68.5% |
| AMC Networks Inc. (AMCX) | 100 | 31.1 | -68.9% |
| Warner Bros. Discov… (WBD) | 100 | 124.6 | +24.6% |
| fuboTV Inc. (FUBO) | 100 | 7.4 | -92.6% |
| The Walt Disney Com… (DIS) | 100 | 92.1 | -7.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CURI vs AMCX vs WBD vs FUBO vs DIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CURI ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 2 yrs, beta 1.30, yield 12.4%
- Beta 1.30, yield 12.4%, current ratio 1.23x
- 12.4% yield, 2-year raise streak, vs DIS's 0.9%, (3 stocks pay no dividend)
AMCX is the clearest fit if your priority is value.
- Lower P/E (5.2x vs 16.0x)
WBD has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 0.87, Low D/E 87.6%, current ratio 1.06x
- Beta 0.87 vs FUBO's 1.80
- +200.9% vs FUBO's -68.3%
FUBO is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 67.7%, EPS growth 96.3%, 3Y rev CAGR 39.2%
- 67.7% revenue growth vs WBD's -5.1%
- 8.1% ROA vs CURI's -8.2%, ROIC -3.3% vs -12.2%
DIS is the clearest fit if your priority is long-term compounding.
- 11.1% 10Y total return vs WBD's -3.7%
- 11.5% margin vs CURI's -9.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 67.7% revenue growth vs WBD's -5.1% | |
| Value | Lower P/E (5.2x vs 16.0x) | |
| Quality / Margins | 11.5% margin vs CURI's -9.0% | |
| Stability / Safety | Beta 0.87 vs FUBO's 1.80 | |
| Dividends | 12.4% yield, 2-year raise streak, vs DIS's 0.9%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +200.9% vs FUBO's -68.3% | |
| Efficiency (ROA) | 8.1% ROA vs CURI's -8.2%, ROIC -3.3% vs -12.2% |
CURI vs AMCX vs WBD vs FUBO vs DIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CURI vs AMCX vs WBD vs FUBO vs DIS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FUBO leads in 1 of 6 categories
WBD leads 1 • CURI leads 1 • AMCX leads 0 • DIS leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CURI and FUBO and DIS each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DIS is the larger business by revenue, generating $97.3B annually — 1357.3x CURI's $72M. DIS is the more profitable business, keeping 11.5% of every revenue dollar as net income compared to CURI's -9.0%. On growth, FUBO holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $72M | $2.3B | $37.2B | $2.7B | $97.3B |
| EBITDAEarnings before interest/tax | $14M | $1.0B | $10.7B | -$14M | $20.5B |
| Net IncomeAfter-tax profit | -$6M | $52M | -$2.2B | $156M | $11.2B |
| Free Cash FlowCash after capex | $13M | $241M | $2.3B | -$81M | $7.1B |
| Gross MarginGross profit ÷ Revenue | +56.6% | +37.3% | +38.2% | +11.1% | +37.2% |
| Operating MarginEBIT ÷ Revenue | -10.2% | +9.2% | +4.5% | -2.6% | +15.5% |
| Net MarginNet income ÷ Revenue | -9.0% | +2.3% | -5.8% | +5.7% | +11.5% |
| FCF MarginFCF ÷ Revenue | +18.1% | +10.5% | +6.2% | -3.0% | +7.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +35.8% | -2.4% | -0.8% | +2.5% | +6.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -31.2% | -2.3% | -5.5% | +81.8% | -29.8% |
Valuation Metrics
Evenly matched — AMCX and FUBO each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 5.3x trailing earnings, AMCX trades at a 94% valuation discount to WBD's 93.5x P/E. On an enterprise value basis, AMCX's 1.6x EV/EBITDA is more attractive than CURI's 23.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $181M | $376M | $68.0B | $302M | $187.5B |
| Enterprise ValueMkt cap + debt − cash | $175M | $1.7B | $96.0B | $520M | $226.7B |
| Trailing P/EPrice ÷ TTM EPS | -28.00x | 5.30x | 93.48x | -42.83x | 15.76x |
| Forward P/EPrice ÷ next-FY EPS est. | 88.00x | 5.19x | — | — | 15.97x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 23.74x | 1.57x | 13.72x | — | 11.83x |
| Price / SalesMarket cap ÷ Revenue | 2.52x | 0.16x | 1.82x | 0.11x | 1.99x |
| Price / BookPrice ÷ Book value/share | 4.28x | 0.49x | 1.85x | 0.11x | 1.71x |
| Price / FCFMarket cap ÷ FCF | 13.96x | 1.38x | 22.01x | — | 18.61x |
Profitability & Efficiency
FUBO leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
FUBO delivers a 16.2% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-13 for CURI. FUBO carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMCX's 1.83x. On the Piotroski fundamental quality scale (0–9), DIS scores 8/9 vs FUBO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -13.1% | +5.0% | -5.9% | +16.2% | +9.8% |
| ROA (TTM)Return on assets | -8.2% | +1.3% | -2.2% | +8.1% | +5.6% |
| ROICReturn on invested capital | -12.2% | +4.0% | +1.5% | -3.3% | +6.9% |
| ROCEReturn on capital employed | -13.6% | +3.9% | +1.5% | -4.1% | +8.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 4 | 8 |
| Debt / EquityFinancial leverage | 0.30x | 1.83x | 0.88x | 0.25x | 0.39x |
| Net DebtTotal debt minus cash | -$6M | $1.3B | $28.0B | $218M | $39.2B |
| Cash & Equiv.Liquid assets | $18M | $502M | $4.6B | $452M | $5.7B |
| Total DebtShort + long-term debt | $12M | $1.9B | $32.6B | $670M | $44.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 1.97x | 2.00x | 10.35x | 9.95x |
Total Returns (Dividends Reinvested)
Evenly matched — CURI and WBD and DIS each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WBD five years ago would be worth $7,276 today (with dividends reinvested), compared to $524 for FUBO. Over the past 12 months, WBD leads with a +200.9% total return vs FUBO's -68.3%. The 3-year compound annual growth rate (CAGR) favors CURI at 53.9% vs FUBO's -22.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.0% | -4.9% | -4.9% | -66.9% | -3.5% |
| 1-Year ReturnPast 12 months | -21.7% | +42.2% | +200.9% | -68.3% | +3.9% |
| 3-Year ReturnCumulative with dividends | +264.4% | -42.4% | +101.4% | -53.9% | +7.3% |
| 5-Year ReturnCumulative with dividends | -68.8% | -81.4% | -27.2% | -94.8% | -40.1% |
| 10-Year ReturnCumulative with dividends | -63.9% | -87.0% | -3.7% | -90.8% | +11.1% |
| CAGR (3Y)Annualised 3-year return | +53.9% | -16.8% | +26.3% | -22.8% | +2.4% |
Risk & Volatility
WBD leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WBD is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than FUBO's 1.80 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WBD currently trades 90.4% from its 52-week high vs FUBO's 18.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 0.94x | 0.87x | 1.80x | 0.91x |
| 52-Week HighHighest price in past year | $7.15 | $10.18 | $30.00 | $56.64 | $124.69 |
| 52-Week LowLowest price in past year | $2.81 | $5.41 | $8.06 | $2.48 | $92.19 |
| % of 52W HighCurrent price vs 52-week peak | +43.1% | +86.4% | +90.4% | +18.1% | +86.6% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 58.9 | 46.6 | 40.4 | 65.7 |
| Avg Volume (50D)Average daily shares traded | 350K | 389K | 22.0M | 1.9M | 9.0M |
Analyst Outlook
CURI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CURI as "Buy", AMCX as "Hold", WBD as "Hold", FUBO as "Hold", DIS as "Buy". Consensus price targets imply 279.4% upside for FUBO (target: $39) vs -3.4% for AMCX (target: $9). For income investors, CURI offers the higher dividend yield at 12.39% vs DIS's 0.92%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $3.67 | $8.50 | $30.06 | $39.00 | $138.44 |
| # AnalystsCovering analysts | 9 | 40 | 32 | 14 | 63 |
| Dividend YieldAnnual dividend ÷ price | +12.4% | — | — | — | +0.9% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 1 | — | 1 |
| Dividend / ShareAnnual DPS | $0.38 | — | — | — | $1.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.9% | 0.0% | 0.0% | +1.9% |
FUBO leads in 1 of 6 categories (Profitability & Efficiency). WBD leads in 1 (Risk & Volatility). 3 tied.
CURI vs AMCX vs WBD vs FUBO vs DIS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CURI or AMCX or WBD or FUBO or DIS a better buy right now?
For growth investors, fuboTV Inc.
(FUBO) is the stronger pick with 67. 7% revenue growth year-over-year, versus -5. 1% for Warner Bros. Discovery, Inc. (WBD). AMC Networks Inc. (AMCX) offers the better valuation at 5. 3x trailing P/E (5. 2x forward), making it the more compelling value choice. Analysts rate CuriosityStream Inc. (CURI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CURI or AMCX or WBD or FUBO or DIS?
On trailing P/E, AMC Networks Inc.
(AMCX) is the cheapest at 5. 3x versus Warner Bros. Discovery, Inc. at 93. 5x. On forward P/E, AMC Networks Inc. is actually cheaper at 5. 2x.
03Which is the better long-term investment — CURI or AMCX or WBD or FUBO or DIS?
Over the past 5 years, Warner Bros.
Discovery, Inc. (WBD) delivered a total return of -27. 2%, compared to -94. 8% for fuboTV Inc. (FUBO). Over 10 years, the gap is even starker: DIS returned +11. 1% versus FUBO's -90. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CURI or AMCX or WBD or FUBO or DIS?
By beta (market sensitivity over 5 years), Warner Bros.
Discovery, Inc. (WBD) is the lower-risk stock at 0. 87β versus fuboTV Inc. 's 1. 80β — meaning FUBO is approximately 108% more volatile than WBD relative to the S&P 500. On balance sheet safety, fuboTV Inc. (FUBO) carries a lower debt/equity ratio of 25% versus 183% for AMC Networks Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CURI or AMCX or WBD or FUBO or DIS?
By revenue growth (latest reported year), fuboTV Inc.
(FUBO) is pulling ahead at 67. 7% versus -5. 1% for Warner Bros. Discovery, Inc. (WBD). On earnings-per-share growth, the picture is similar: The Walt Disney Company grew EPS 151. 8% year-over-year, compared to 54. 2% for CuriosityStream Inc.. Over a 3-year CAGR, FUBO leads at 39. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CURI or AMCX or WBD or FUBO or DIS?
The Walt Disney Company (DIS) is the more profitable company, earning 13.
1% net margin versus -9. 0% for CuriosityStream Inc. — meaning it keeps 13. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DIS leads at 14. 6% versus -10. 2% for CURI. At the gross margin level — before operating expenses — CURI leads at 56. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CURI or AMCX or WBD or FUBO or DIS more undervalued right now?
On forward earnings alone, AMC Networks Inc.
(AMCX) trades at 5. 2x forward P/E versus 88. 0x for CuriosityStream Inc. — 82. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FUBO: 279. 4% to $39. 00.
08Which pays a better dividend — CURI or AMCX or WBD or FUBO or DIS?
In this comparison, CURI (12.
4% yield), DIS (0. 9% yield) pay a dividend. AMCX, WBD, FUBO do not pay a meaningful dividend and should not be held primarily for income.
09Is CURI or AMCX or WBD or FUBO or DIS better for a retirement portfolio?
For long-horizon retirement investors, The Walt Disney Company (DIS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
91), 0. 9% yield). fuboTV Inc. (FUBO) carries a higher beta of 1. 80 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DIS: +11. 1%, FUBO: -90. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CURI and AMCX and WBD and FUBO and DIS?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CURI is a small-cap high-growth stock; AMCX is a small-cap deep-value stock; WBD is a mid-cap quality compounder stock; FUBO is a small-cap high-growth stock; DIS is a mid-cap deep-value stock. CURI, DIS pay a dividend while AMCX, WBD, FUBO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 17%
- Gross Margin > 33%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.